Carlumab

Modify Date: 2024-04-05 21:53:05

Carlumab structure	Common Name	Carlumab
	CAS Number	915404-94-3	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Carlumab

Carlumab (CNTO 888) is a humanised anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer[1].

Name	Carlumab

Description	Carlumab (CNTO 888) is a humanised anti-CCL2 (chemokine ligand 2) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> CCR Research Areas >> Cancer Signaling Pathways >> Immunology/Inflammation >> CCR
Target	CCL2[1].
References	[1]. Fetterly GJ, et al.. Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. J Clin Pharmacol. 2013 Oct;53(10):1020-7.

No Any Chemical & Physical Properties